2023
DOI: 10.23851/mjs.v33i5.1307
|View full text |Cite
|
Sign up to set email alerts
|

Identification of a Methylation Pattern in the SNRPN Gene Promoter and its Association with Semen Abnormality Among Iraqi Males

Abstract: Infertility considered as a multifactorial condition; the small nuclear ribonucleoprotein polypeptide N (SNRPN) gene is an imprinted gene. However, abnormal imprinting of this gene due to the methylation may result in abnormal function or silencing of the gene. Main aim of this study is to investigate the methylation present at the promoter of (SNRPN) gene and its role as a risk factor for male infertility. Sixty- three infertile males with age mean (32.28 ± 6.88 years) and 13 fertile males as a control age me… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 13 publications
0
1
0
Order By: Relevance
“…MicroRNA-126 has been linked to the development of several disorders, one of these are autoimmune disorders (19). MicroRNA-126 may serve as a biomarker for diabetes since its expression is downregulated in autoimmune disorders like diabetes mellitus (20).Single nucleotide polymorphism SNPs are genetic variations that may affect a protein's structure or functionality (36,38,40). Also, circulating miRNA-126 has been reported as a potential biomarker for nonalcoholic fatty liver disease (1).…”
mentioning
confidence: 99%
“…MicroRNA-126 has been linked to the development of several disorders, one of these are autoimmune disorders (19). MicroRNA-126 may serve as a biomarker for diabetes since its expression is downregulated in autoimmune disorders like diabetes mellitus (20).Single nucleotide polymorphism SNPs are genetic variations that may affect a protein's structure or functionality (36,38,40). Also, circulating miRNA-126 has been reported as a potential biomarker for nonalcoholic fatty liver disease (1).…”
mentioning
confidence: 99%